Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures

Journal of Neuroscience

Volumn 19, Issue 12, 1999, Pages 5054-5065

  Vezzani, Annamaria ^a,b   Conti, Mirko ^a   De Luigi, Ada ^b   Ravizza, Teresa ^a   Moneta, Daniela ^a   Marchesi, Francesco ^a   De Simoni, Maria Grazia ^b  

^a Institute of Experimental Neurology   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Bicuculline; Cytokines; EEG; Epilepsy; Inflammation; Interleukin (IL) 1Ra; Neurodegeneration

Indexed keywords

BICUCULLINE; CYTOKINE; INTERLEUKIN 1 DERIVATIVE; KAINIC ACID; 3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; ANTIBODY; ANTICONVULSIVE AGENT; ANTIRHEUMATIC AGENT; GLUTAMIC ACID; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; SIALOGLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GLIA CELL; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; ANIMAL; CELL COUNT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; IMMUNOLOGY; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES; ANTICONVULSANTS; ANTIRHEUMATIC AGENTS; BICUCULLINE; CELL COUNT; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; GABA ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KAINIC ACID; MALE; MICROGLIA; NERVE DEGENERATION; NEURONS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SIALOGLYCOPROTEINS;

EID: 0033563321     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-12-05054.1999     Document Type: Article

References (72)

1. Akassoglou K, Probert L, Kontogeorgos G, Kollias G (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgcnic mice. J Immunol 158:438-445.
2. Amaral DG, Witter MP (1995) Hippocampal formation. In: Hippocampus (Paxinos G, ed), pp 443-493. San Diego: Academic.
3. Andersson PB, Perry VH, Gordon S (1991) The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42:201-214.
4. Arend WP, Welgus HG, Thompson RC, Eisenberg SP (1990) Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 85:580-583.
5. Ban E, Milon G, Fillion G, Haour F (1991) Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43:21-30.
6. Barres BA (1991) New roles for glia. J Neurosci 11:3685-3694.
7. Bartfai T, Schultzberg M (1993) Cytokines in neuronal cell types. Neurochem Int 22:435-444.
8. Bellinger FP, Madamba S, Siggins GR (1993) Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234.
9. Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 263:C1-C16.
10. Bristow AF, Mosley K, Poole S (1991) Interleukin-1β production in vivo and in vitro in rats and mice measured using specific immunoradiometric assays. J Mol Endocrinol 7:1-7.
11. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurological disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065.
12. Clifford DB, Olney JW, Benz AM, Fuller TA, Zorumski CF (1990) Ketamine, phencyclidine and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 31:382-390.
13. Coogan A, O'Connor JJ (1997) Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. NeuroReport 8:2107-2110.
14. Cunningham AJ, Murray CA, O'Neill LAJ, Lynch MA, O'Connor JJ (1996) Interleukin-1β (IL-1β) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20.
15. Curtis DR, Duggan AW, Felix D, Johnston GA (1970) GABA, bicuculline and central inhibition. Nature 226:1222-1224.
16. D'Arcangelo G, Dodt H, Zieglgansberger W (1997) Reduction of excitation by interleukin-1β in rat neocortical slices visualized using infrared-darkfield video microscopy. NeuroReport 8:2079-2083.
17. 3H)D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res 382:169-173.
18. de Bock F, Dornand J, Rondouin G (1996) Release of TNFa in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport 7:1125-1129.
19. De Luigi A, Terreni L, Sironi M, De Simoni MG (1998) The sympathetic nervous system tonically inhibits peripheral IL-1β and IL-6 induction by central lipopolysaccharide. Neuroscience 83:1245-1250.
20. De Simoni MG, Imeri L (1998) Cytokine-neurotrasmitter interactions in the brain. Biol Signals 7:33-44.
21. Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, Libby P (1987) Interleukin-1. I. Induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 139:1902-1906.
22. Eisenberg SP, Evans RJ, Arend WP, Verber E, Brewer MT, Hannun CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346.
23. Eriksson C, Winblad B, Schltzberg M (1998) Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Mol Brain Res 58:195-208.
24. Ferkany J, Coyle JT (1983) Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J Pharmacol Exp Ther 225:399-406.
25. Garabedian BS, Poole S, Allchorne A, Winter J, Woolf C (1995) Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115:1265-1275.
26. Gariboldi M, Conti M, Cavaleri D, Samanin R, Vezzani A (1998) Anticonvulsant properties of BIBP 3226, a non-peptide selective antagonist at neuropeptide Y Y-1 receptors. Eur J Neurosci 10:757-759.
27. Giulian D, Baker TJ, Shih LC, Lachman LB (1986) Interleukin-1 in the central nervous system is produced by ameboid microglia. J Exp Med 164:594-604.
28. Hagan P, Poole S, Bristow AF, Tilders F, Siverstein FS (1996) Intracerebral NMDA injection stimulates production of interleukin-1β in perinatal rat brain. J Neurochem 67:2215-2218.
29. Hewett SJ, Csernansky CA, Choi DW (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13:487-494.
30. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. In: Annual review of neuroscience (Cowan MW, Shooter EM, Stevens CF, Thompson RF, eds), pp 31-108. Palo Alto, CA: Annal Reviews.
31. Hopkins SJ, Rothwell NJ (1995) Cytokine and the nervous system I: expression and recognition. Trends Neurosci 18:83-88.
32. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990) Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323-326.
33. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
34. Lapchak PA, Araujo DM, Hefti F (1993) Systemic interleukin-1β decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 53:297-301.
35. Lason W, Simpson JN, McGinty JF (1988) Effects of D-(-)-aminophosphonovalerate on behavioral and histological changes induced by systemic kainic acid. Neurosci Lett 87:23-28.
36. Lawrence CB, Allan SM, Rothwell NJ (1998) Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 10:1188-1195.
37. Li A-J, Katafuchi T, Oda S, Hori T, Oomura Y (1997) Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748:30-38.
38. Linthorst ACE, Flachskam C, Holsboer F, Reul JMHM (1994) Local administration of recombinant human interleukin-1β in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology 135:520-532.
39. Liu Z, Gatt A, Mikati M, Holmes GL (1993) Effect of temperature on kainic acid-induced seizures. Brain Res 631:51-58.
40. Loddick SA, Rothwell NJ (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16:932-940.
41. Mascarucci P, Perego C, Terrazzino S, De Simoni MG (1998) Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1β. Neuroscience 86:1285-1290.
42. Miller LG, Galpern WR, Dunlap K, Dinarello CA, Turner TJ (1991) Interleukin-1 augments γ-aminobutyric acid receptor function in brain. Mol Pharmacol 39:105-108.
43. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M (1990) Convulsants induce interleukin-1β messenger RNA in rat brain. Biochem Biophys Res Commun 171:823-827.
44. Minami M, Kuraishi Y, Satoh M (1991) Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα, and Lif in the rat brain. Biochem Biophys Res Commun 176:593-598.
45. Morganti-Kossmann MC, Kossmann T, Wahl SM (1992) Cytokines and neuropathology. Trends Pharmacol Sci 131:286-290.
46. Nishiyori A, Minami M, Takami S, Satoh M (1997) Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Mol Brain Res 50:237-245.
47. Nitsch C, Goping G, Klatzo I (1986) Pathophysiological aspects of blood-brain barrier permeability in epilectic seizures. Adv Exp Med Biol 203:175-189.
48. Paxinos G, Watson C (1986) The rat stereotaxic atlas. New York: Academic.
49. Plata-Salamàn CR, ffrench-Mullen JMH (1992) Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 29:221-223.
50. Rothwell NJ (1991) Functions and mechanism of interleukin-1 in the brain. Trends Pharmacol Sci 12:430-436.
51. Rothwell NJ, Hopkins SJ (1995) Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18:130-136.
52. Scarborough DE, Lee SL, Dinarello CA, Reichlin S (1989) Interleukin-1β stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology 124:549-551.
53. Scharfman HE (1997) Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol 78:1082-1095.
54. Schobitz B, De Kloet ER, Holsboer F (1994) Gene expression and function of interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44:397-342.
55. Schwarzer C, Sperk G, Samanin R, Rizzi M, Gariboldi M, Vezzani A (1996) Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res Rev 22:27-50.
56. Sheng JG, Boop FA, Mrak RE, Griffin WST (1994) Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity. J Neurochem 63:1872-1879.
57. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Naher-Noè M, Thoenen H (1990) Regulation of Nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 2:69-76.
58. Streit WJ (1990) An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J Histochem Cytochem 38:1683-1686.
59. Takao T, Tracey DE, Mitchell WM, de Souza EB (1990) Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127:3070-3078.
60. Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146:176-178.
61. Taniwaki Y, Kato M, Araki T, Kobayashi T (1996) Microglial activation by epilectic activities through the propagation pathway of kainic acid induced hippocampal seizures in the rat. Neurosci Lett 217:29-32.
62. Traub RD, Miles R, Jefferys JG (1993) Synaptic and intrinsic conductances shape picrotoxin-induced synchronized after-discharges in the guinea-pig hippocampal slice. J Physiol (Lond) 461:525-547.
63. Turski WA, Cavalheiro EA, Calderazzo-Filho LS, Kleinrok Z, Czuczwar SJ, Turski L (1985) Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioral and morphological analysis. Neuroscience 14:37-53.
64. Vezzani A, Wu HQ, Tullii M, Samanin R (1986) Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. J Pharmacol Exp Ther 239:256-262.
65. Vezzani A, Serafini R, Stasi MA, Vigano' G, Rizzi M, Samanin R (1991) A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology 30:345-352.
66. Watkins JC (1978) Excitatory amino acids. In: Kainic acid as a tool in neurobiology (McGeer EG, Olney JW, McGeer PL, eds), pp 37-69. New York: Raven.
67. Westbrook GL, Lothman EW (1983) Cellular and synaptic basis of kainic acid-induced hippocampal epileptiform activity. Brain Res 273:97-109.
68. Yabuuchi K, Minami M, Katsumata S, Satoh M (1993) In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Mol Brain Res 20:153-161.
69. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itojama Y, Kogure K (1995) Interleukin-1 as a pathogenetic mediator of ischemic bain damage in rats. Stroke 26:676-681.
70. Ye Z, Sontheimer H (1996) Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. NeuroReport 7:2181-2185.
71. Young AMG, Crowder JM, Bradford HF (1988) Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J Neurochem 50:337-345.
72. Zeise ML, Espinoza J, Morales P, Nalli A (1997) Interleukin-1β does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res 768:341-344.